Related Experiment Video

Updated: Aug 24, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Expression of protein kinase C isoforms and interleukin-1beta in myofibrillar myopathy

G Vattemi1, P Tonin, M Mora

  • 1Department of Neurological Sciences and Vision, Section of Clinical Neurology, Clinica Neurologica, Policlinico G.B. Rossi, Verona, Italy.

Neurology
|May 26, 2004
PubMed
Abstract

Insights

Protein kinase C and interleukin-1beta may contribute to myofibrillar myopathy, a rare muscle disorder characterized by protein abnormalities. Further research is needed to understand this complex condition.

Area of Science:

  • Neurology
  • Muscle Biology
  • Biochemistry

Background:

  • Myofibrillar myopathy is a rare, heterogeneous muscle disorder with poorly understood pathogenesis.
  • Characterized by myofibrillar destruction and abnormal protein expression, notably desmin.
  • This study focuses on the role of specific protein kinase C (PKC) isoforms and interleukin-1beta (IL-1β) in disease development.

Purpose of the Study:

  • To investigate the involvement of protein kinase C isoforms and interleukin-1beta in the pathogenesis of myofibrillar myopathy.
  • To analyze protein expression in muscle fibers of patients with myofibrillar myopathy.

Main Methods:

  • Studied eight patients from four families with myofibrillar myopathy.
  • Utilized immunohistochemical analysis to detect protein expression.
  • Employed immunoblots to confirm protein expression patterns.

Main Results:

  • Immunohistochemistry revealed expression of PKC alpha, eta, and zeta isoforms, and IL-1β in affected muscle fibers.
  • Immunoblots confirmed these findings and showed absence of PKC delta and epsilon in patient and control muscle fibers.
  • Abnormal expression patterns of specific PKC isoforms and IL-1β were observed in myofibrillar myopathy.

Conclusions:

  • Protein kinase C and interleukin-1beta are implicated in the pathogenesis of myofibrillar myopathy.
  • These findings provide insights into the molecular mechanisms underlying this rare muscle disease.
  • Suggests potential therapeutic targets for myofibrillar myopathy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Types of Intermediate Filaments01:31

Types of Intermediate Filaments

The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...